Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Adenocarcinoma In Situ · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Carcinoma
Carcinoma In Situ
Adenocarcinoma In Situ

Histology

Adenocarcinoma In Situ

CI-CAN-00001682AISExplore in graph →

61 active trials

NCIt: C4123
OncoTree: AIS
UMLS CUI: C0334276
MeSH: D065311

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials210
Research
Rankings
Sources & provenance

Data completeness2 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (no data yet)
Evidence (no data yet)
Therapies (no data yet)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A lesion in which the normally situated glands are partially or completely replaced by atypical cells with malignant characteristics.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

AdenocarcinomaHistology
Carcinoma In SituHistology

Children (9)

ncit

Adenocarcinoma In Situ in Adenomatous Polyp
Adenocarcinoma In Situ in Tubular Adenoma
Adenocarcinoma In Situ in Tubulovillous Adenoma
Adenocarcinoma In Situ in Villous Adenoma
Breast Carcinoma In Situ5 sub
Cervical Adenocarcinoma In Situ2 sub
Grade III Glandular Intraepithelial Neoplasia1 sub
Lung Adenocarcinoma In Situ2 sub

Anatomy

Anatomical sites

OtherC17649

Record

Identity

CancerIndex ID: CI-CAN-00001682
Entity type: Histology
Malignant: Yes
Solid / hematologic: Solid tumor
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 5
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active): 210 / 61

Serous Tubal Intraepithelial Carcinoma

36 descendants in total; counters on this page aggregate over all of them.

Publications (all / 5y)

341 / 136

Evidence items

0

Genes / variants

0 / 0

Drugs (any / approved)

0 / 0

Genomic cohorts

0

Epidemiology / survival obs.

0 / 0

Data updated 18 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (7)

Adenocarcinoma in Situmesh_heading · MeSH
Adenocarcinoma In Situsynonym · OncoTree
Adenocarcinoma in Situssynonym · MeSH
Adenocarcinoma, Intraepithelialsynonym · MeSH
Adenocarcinoma, Preinvasivesynonym · MeSH
Adenocarcinomas, Intraepithelialsynonym · MeSH
Adenocarcinomas, Preinvasivesynonym · MeSH

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

No registry-level ancestor: burden figures are published for the mutually exclusive top-level site groups only, and this entity does not descend from one. Global figures (IARC / GLOBOCAN) stay under license review and SEER awaits credentials.

Active trials61countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #255 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials31countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #264 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items0countaccepted CIViC items · entity + descendantscivicComputednot in a current ranking snapshot
Publications, last 12 months10countPubMed records · stored query · 12-month windowpubmedComputedrank #991 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts0countopen GDC projects · entity + descendantsgdcComputednot in a current ranking snapshot

Data updated 18 hours agoSource updated unknownregistry figures: none · counters aggregate over descendants